Biography of Mark Velleca
Last update: March 14, 2024Career
Mark was Chief Executive Officer at StrideBio, and Chief Executive Officer at G1 Therapeutics. Mark served as Director and Chairman of the Board for StrideBio.
Mark Velleca is currently- Chief Executive Officer and Director at Black Diamond Therapeutics - View - Black Diamond Therapeutics org chart
- Chief Executive Officer at StrideBio - View - StrideBio org chart
- Executive Chairman of the Board at Myeloid Therapeutics - View - Myeloid Therapeutics org chart
Create your alert
to follow the career of Mark Velleca.
Education
Mark Velleca has a Bachelor of Science from Yale University and a PhD from Washington University.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at Washington University :
Find more alumni from Washington University
More about Mark Velleca
Selected links
Do you need to know more about Mark Velleca? More results.
Participate
Social media
- Mark Velleca on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Mark Velleca
The colleagues of Mark Velleca
Company Colleagues
- At Black Diamond Therapeutics, Mark Velleca has 19 colleagues including Garry Menzel (Director), David Epstein (Director)…
- At StrideBio, Mark Velleca has 15 colleagues including Kristina Allikmets (Director), Erica Whitaker (Director)…
- At Myeloid Therapeutics, Mark Velleca has 14 colleagues including Daniel Getts (CEO & Director), Brett Kaplan (Director)…
Industry Colleagues
- In the Biotechnology industry, Mark Velleca has 30,214 colleagues in 2,277 companies located in 40 countries. 14,238 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mark Velleca.
Get in Touch
and ask for Mark Velleca.
